Rex Quaempts, MD | |
401 Buster Rd, Toppenish, WA 98948-9792 | |
(509) 865-1705 | |
(509) 865-4986 |
Full Name | Rex Quaempts |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 32 Years |
Location | 401 Buster Rd, Toppenish, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730255910 | NPI | - | NPPES |
8204364 | Medicaid | WA |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Yellowhawk Tribal Health Center | 6608924121 | 14 |
News Archive
Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today the publication of new data in the journal Nature Medicine describing the role of the tumor suppressor miRNA, miR-34, in preventing cancer stem cell development. The published results reveal that miR-34 is commonly down-regulated in prostate cancer stem cells and that this down-regulation is essential for cancer stem cell viability.
Cognitive behavioral therapy delivered in a primary care setting is a cost-effective way to treat adolescents with depression who decline or quickly stop using antidepressants, according to a Kaiser Permanente study published today in the journal Pediatrics.
Brown University, in collaboration with two other institutions, has been awarded a five-year, $6-million National Institutes of Health program project grant to help determine how a virus that can cause a rare brain disease attaches to host cells.
A new variant of the virus that causes COVID-19, identified in Brazil, is likely more transmissible than its parent strain because of mutations in the spike protein, according to researchers.
Elderly, community-dwelling individuals who visit hospital with an acute illness are less likely to be transferred to skilled nursing facilities if they receive an intensified type of rehabilitation rather than usual rehabilitative care, report US researchers.
› Verified 1 days ago
Entity Name | Yakama Indian Health Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528105541 PECOS PAC ID: 0749206985 Enrollment ID: O20051018000438 |
News Archive
Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today the publication of new data in the journal Nature Medicine describing the role of the tumor suppressor miRNA, miR-34, in preventing cancer stem cell development. The published results reveal that miR-34 is commonly down-regulated in prostate cancer stem cells and that this down-regulation is essential for cancer stem cell viability.
Cognitive behavioral therapy delivered in a primary care setting is a cost-effective way to treat adolescents with depression who decline or quickly stop using antidepressants, according to a Kaiser Permanente study published today in the journal Pediatrics.
Brown University, in collaboration with two other institutions, has been awarded a five-year, $6-million National Institutes of Health program project grant to help determine how a virus that can cause a rare brain disease attaches to host cells.
A new variant of the virus that causes COVID-19, identified in Brazil, is likely more transmissible than its parent strain because of mutations in the spike protein, according to researchers.
Elderly, community-dwelling individuals who visit hospital with an acute illness are less likely to be transferred to skilled nursing facilities if they receive an intensified type of rehabilitation rather than usual rehabilitative care, report US researchers.
› Verified 1 days ago
Entity Name | Yellowhawk Tribal Health Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346283488 PECOS PAC ID: 6608924121 Enrollment ID: O20090511000179 |
News Archive
Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today the publication of new data in the journal Nature Medicine describing the role of the tumor suppressor miRNA, miR-34, in preventing cancer stem cell development. The published results reveal that miR-34 is commonly down-regulated in prostate cancer stem cells and that this down-regulation is essential for cancer stem cell viability.
Cognitive behavioral therapy delivered in a primary care setting is a cost-effective way to treat adolescents with depression who decline or quickly stop using antidepressants, according to a Kaiser Permanente study published today in the journal Pediatrics.
Brown University, in collaboration with two other institutions, has been awarded a five-year, $6-million National Institutes of Health program project grant to help determine how a virus that can cause a rare brain disease attaches to host cells.
A new variant of the virus that causes COVID-19, identified in Brazil, is likely more transmissible than its parent strain because of mutations in the spike protein, according to researchers.
Elderly, community-dwelling individuals who visit hospital with an acute illness are less likely to be transferred to skilled nursing facilities if they receive an intensified type of rehabilitation rather than usual rehabilitative care, report US researchers.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Rex Quaempts, MD 401 Buster Rd, Toppenish, WA 98948-9792 Ph: (509) 865-1705 | Rex Quaempts, MD 401 Buster Rd, Toppenish, WA 98948-9792 Ph: (509) 865-1705 |
News Archive
Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today the publication of new data in the journal Nature Medicine describing the role of the tumor suppressor miRNA, miR-34, in preventing cancer stem cell development. The published results reveal that miR-34 is commonly down-regulated in prostate cancer stem cells and that this down-regulation is essential for cancer stem cell viability.
Cognitive behavioral therapy delivered in a primary care setting is a cost-effective way to treat adolescents with depression who decline or quickly stop using antidepressants, according to a Kaiser Permanente study published today in the journal Pediatrics.
Brown University, in collaboration with two other institutions, has been awarded a five-year, $6-million National Institutes of Health program project grant to help determine how a virus that can cause a rare brain disease attaches to host cells.
A new variant of the virus that causes COVID-19, identified in Brazil, is likely more transmissible than its parent strain because of mutations in the spike protein, according to researchers.
Elderly, community-dwelling individuals who visit hospital with an acute illness are less likely to be transferred to skilled nursing facilities if they receive an intensified type of rehabilitation rather than usual rehabilitative care, report US researchers.
› Verified 1 days ago
Dr. Rory C Sumners, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Buster Rd, Toppenish, WA 98948 Phone: 509-865-2102 Fax: 509-865-5374 | |
Jayme Thompson, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 510 W 1st Ave, Toppenish, WA 98948 Phone: 509-865-5600 Fax: 509-865-5783 | |
George Lupas, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 510 W 1st Ave, Toppenish, WA 98948 Phone: 509-865-5600 Fax: 509-865-5783 | |
Donn Kruse, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 401 Buster Rd, Toppenish, WA 98948 Phone: 509-865-2102 | |
Danial Hocson, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Buster Rd, Toppenish, WA 98948 Phone: 509-865-2102 | |
Sharon Dietrich, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 518 W 1st Ave, Toppenish, WA 98948 Phone: 509-865-5600 Fax: 509-865-5783 | |
Clara E Monheit, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 510 W 1st Ave, Toppenish, WA 98948 Phone: 509-865-5600 Fax: 509-865-5783 |